DRIO· Health Care› Health Information Services

DarioHealth Corp.

Stage 4 · Declining · week 3

As of Oct 22, 2026, DarioHealth is in Stage 4, the downtrend phase, now in week 3 (since Oct 2, 2026). It closed at $3.41, 78.9% below its 52-week high and below its 200-day average, which is falling.

DarioHealth Corp. operates as a digital health company in the United States and internationally. More about the company

$3.41

-7.34% today

$33.4M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is DRIO early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 23w

S4 31w

S4 21w

S4 36w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 23w → S1 9w → S4 31w → S1 4w → S4 21w → S1 12w → S4 13w → S1 5w → S2 4w → S3 1w → S4 36w → S1 4w → S4 3w current

Total tracked: 165 weeks across 13 stage runs.

DRIO among Health Information Services33rd of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…33	DRIODarioHealth Corp.	Stage 4 · wk 3	13	−49.4%

vs 52W High

-78.9%

$3.41 lo$16.19 hi

78.9% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-57.4%

200 DMA: $8.00 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

6.75x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-49.4%

-56.2%

-52.6%

YTD

-67.6%

-76.4%

Scan Membership

Breakout Watch

Latest: 2023-03-21

6 appearances in last 60 days. First seen: 2019-11-22.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 6.75x

2026-10-21S4

Wk 3 · Vol 10.54x

2026-10-20S4

Wk 3 · Vol 5.76x

2026-10-19S4

Wk 3 · Vol 1.35x

2026-10-16S4

Wk 3 · Vol 1.17x

2026-10-15S4

Wk 2 · Vol 0.45x

2026-10-14S4

Wk 2 · Vol 0.26x

2026-10-13S4

Wk 2 · Vol 0.35x

2026-10-12S4

Wk 2 · Vol 0.41x

2026-10-09S4

Wk 2 · Vol 0.10x

2026-10-08S4

Wk 1 · Vol 1.52x

2026-10-07S4

Wk 1 · Vol 0.10x

Moving averages & range

50 DMA

$6.45

200 DMA

$8.00

52W High

$16.19

52W Low

$3.41

5D Low

$3.41

Resistance levels (recent highs)

20d High

$6.71

60d High

$7.75

120d High

$8.68

250d High

$16.19

Next resistance

+96.8%

to 20d High

ROE

-59.9%

Profit margin -169.9%

Dividend Yield

0.00%

P/B 0.5

DarioHealth: quick answers

What stage is DarioHealth in?

As of Oct 22, 2026, DarioHealth (DRIO) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 2, 2026 and is in week 3. What the four stages mean

Is DarioHealth in an uptrend?

No. DarioHealth is in a Stage 4 downtrend. It trades 57.4% below its 200-day average, which is falling.

How far is DarioHealth from its 52-week high?

DarioHealth closed at $3.41 on Oct 22, 2026, 78.9% below its 52-week high of $16.19. Its 52-week low is $3.41.

How has DarioHealth performed over the past year?

As of Oct 22, 2026, DarioHealth is down 76.4% over the past year and down 67.6% so far in 2026.

Which sector and industry is DarioHealth in?

DarioHealth is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.